drugset / Trial / NCT03313596
Multicenter RCT of ADV-TK Gene Therapy Improving the Outcome of Liver Transplantation for Advanced HCC
Phase 3
Unknown
180 enrolled
Huazhong University of Science and Technology
Beijing YouAn Hospital · collab
RandomizedParallel-groupSingle-blindTreatment
Summary
Compare the effect of liver transplantation (LT) plus ADV-TK gene therapy versus LT only in advanced primary hepatocellular carcinoma.
Timeline
- Start
- 2013-03
- Primary completion
- 2019-12
- Completion
- 2019-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | aglatimagene besadenovec | Unknown | 1e+12 vg | Other |